PSB-1491

CAS No. 1619884-67-1

PSB-1491( PSB 1491 | PSB1491 )

Catalog No. M27789 CAS No. 1619884-67-1

PSB-1491 is a selective and competitive monoamine oxidase B inhibitor with IC50 of 0.386 nM, >25000-fold selective versus MAO-A.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 302 Get Quote
10MG 447 Get Quote
25MG 714 Get Quote
50MG 1017 Get Quote
100MG 1368 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    PSB-1491
  • Note
    Research use only, not for human use.
  • Brief Description
    PSB-1491 is a selective and competitive monoamine oxidase B inhibitor with IC50 of 0.386 nM, >25000-fold selective versus MAO-A.
  • Description
    PSB-1491 is a selective and competitive monoamine oxidase B inhibitor with IC50 of 0.386 nM, >25000-fold selective versus MAO-A.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    PSB 1491 | PSB1491
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    MAO
  • Recptor
    Human Endogenous Metabolite
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1619884-67-1
  • Formula Weight
    320.17
  • Molecular Formula
    C15H11Cl2N3O
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    Cn1ncc2cc(ccc12)C(=O)Nc1ccc(Cl)c(Cl)c1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Brunner H, et al. The effects of 5-aminolevulinic acid esters on protoporphyrin IX production in human adenocarcinoma cell lines. Photochem Photobiol. 2001 Nov;74(5):721-5.
molnova catalog
related products
  • Furazolidone

    Furazolidone is a nitrofuran derivative with antiprotozoal and antibacterial activity, inhibits AML1-ETO transformed cells with IC50 value of 12.7 μM.

  • Rasagiline Mesylate

    Rasagiline Mesylate is a new MAO-B inhibitor for the treatment of idiopathic Parkinson's disease.

  • Salvigenin

    Salvigenin is a potent hMAO-A inhibitor has neuroprotective antitumor and immunomodulatory effects.